Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Immune cells affect hair growth and could lead to new hair loss treatments.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Finasteride can cause a unique skin reaction on the penile shaft.

Synthetic ceramides may help hair growth by boosting cell growth in hair follicles.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

Baricitinib is effective and safe for treating severe alopecia areata.

Hair disorders in organ transplant patients are often underestimated and need more attention and research.

Kidney transplant patients often have skin issues, mainly infections.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Plantain has potential medicinal benefits but needs more research for safety and effectiveness.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Using Arabidopsis thaliana to produce KGF-2 is a promising, cost-effective method for hair growth and wound healing products.